Home
Market Capitalization of Procter & Gamble Health Ltd

Procter & Gamble Health Ltd
NSE: PGHL
Market Cap
Key Highlights
- The Market Cap of Procter & Gamble Health Ltd is ₹ 8781 crore as of 21 Feb 25 .
- The Latest Trading Price of Procter & Gamble Health Ltd is ₹ 5290 as of 21 Feb 15:30 .
- The Dividend Payouts of Procter & Gamble Health Ltd changed from ₹ 45 on Feb 13, 2023 to ₹ 80 on Feb 21, 2025 . This represents a CAGR of 10.06% over 6 years.

Procter & Gamble Health Ltd
NSE: PGHL
Share Price
Market Price of Procter & Gamble Health Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 5290.5 |
20 Feb 2025 | 5323.4 |
19 Feb 2025 | 5302.8 |
18 Feb 2025 | 5311.15 |
17 Feb 2025 | 5299.55 |
14 Feb 2025 | 5224.55 |
13 Feb 2025 | 5303.1 |
12 Feb 2025 | 5365 |
11 Feb 2025 | 5259.7 |
10 Feb 2025 | 5332.55 |
SWOT Analysis Of Procter & Gamble Health Ltd
BlinkX Score for Procter & Gamble Health Ltd
Asset Value vs Market Value of Procter & Gamble Health Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Procter & Gamble Health Ltd
Historical P/E Ratio of Procter & Gamble Health Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Procter & Gamble Health Ltd
Historical Revenue of Procter & Gamble Health Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Procter & Gamble Health Ltd
Historical EBITDA of Procter & Gamble Health Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Procter & Gamble Health Ltd
Historical Net Profit of Procter & Gamble Health Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Procter & Gamble Health Ltd
Historical Dividend Payouts of Procter & Gamble Health Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payouts of Procter & Gamble Health Ltd
About Procter & Gamble Health Ltd
- Procter & Gamble Health Limited (formerly Merck Limited), is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.
- The company is the supplier of Pharmaceutical Chemicals, Formulated Chemical Products, Chemicals, Industrial Chemicals, Chemicals, Pharmaceutical Industry, and Chemical Products. The company offers prescription drugs, biotechnology products, and consumer health products, including over-the-counter products.
- They also offer products for the treatment of cancer, neurodegenerative diseases, infertility, endocrine and metabolic disorders, cardiovascular diseases, and other conditions with unmet medical needs. The company operates in two business divisions, namely Pharmaceuticals and Chemicals.
- The Pharmaceuticals business comprises of Ethicals used in the treatment of Cardiovascular and Metabolic diseases & Vitamin-based formulations and Consumer Health Care Products.
Procter & Gamble Health Ltd News Hub
P&G Health slides as Q4 PAT drops 44% YoY to Rs 17 cr
Revenue from operations slipped 5.74% year on year to Rs 283.88 crore during the quarter, owing to c
Read more
22 Aug 24
Board of Procter & Gamble Health recommends final dividend
Procter & Gamble Health announced that the Board of Directors of the Company at its meeting held on
Read more
21 Aug 24
Procter & Gamble Health to pay final dividend
Procter & Gamble Health announced that final dividend of Rs 60 per share for FY 2024 will be paid by
Read more
21 Aug 24
Broader market outperforms; European mkt opens higher
The headline equity indices traded with decent gains in afternoon trade. The Nifty hovered above the
Read more
22 Aug 24